跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方达克罗宁薄荷溶液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Dyclonine Hydrochloride and Monthal Solution
Approved
化学药品
Compound Dyclonine Hydrochloride and Monthal Solution
常熟市星海制药有限公司
🇨🇳 National Medical Products Administration
Approval Date
Jul 9, 2020
Approval ID
7Leaf9LzgG8
Company
常熟市星海制药有限公司
Type
化学药品
Approval Details
Approval Id
7Leaf9LzgG8
Approval Number
国药准字H32025474
Generic Name
复方达克罗宁薄荷溶液
Generic Name En
Compound Dyclonine Hydrochloride and Monthal Solution
Drug Type
化学药品
Dosage Form
溶液剂(外用)
Strength
复方
Reg Date
2020-07-09
Company Name
常熟市星海制药有限公司
Production Company Name
常熟市星海制药有限公司
Production Company Address
常熟市碧溪新区(浒浦)留下工业园
Company Detail Path
/organization/chang-shou-shi-xing-hai-zhi-yao-you-xian-gong-si
Production Company Detail Path
/organization/chang-shou-shi-xing-hai-zhi-yao-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 9, 2020
Approval ID
7Leaf9LzgG8
Type
化学药品
Back to NMPA Approvals